Rheumatology News & Research | Hospital Healthcare EuropHospital Healthcare Europe

This website is intended for healthcare professionals only.

Rheumatology

risankizumab

Risankizumab approved by EMA for active psoriatic arthritis

$dairy and fractures$

Fracture incidence reduced by a third in elderly with higher dairy intake

systemic lupus erythematosus

Healthy lifestyle associated with lower risk of systemic lupus erythematosus

systemic juvenile idiopathic arthritis

Early biologic use in systemic juvenile idiopathic arthritis reduces need for steroids

ankylosing sp

Upadacitinib effective over one year in ankylosing spondylitis

ustekinumab

Ustekinumab equivalent to TNF inhibitors in psoriatic arthritis real-world study

Interleukin-6 antagonists and COVID mortality benefit

Mortality benefit in COVID-19 from interleukin-6 antagonists

colchicine in COVID-19

Large trial suggests no benefit from colchicine on COVID-19 mortality

cannabinoids and rheumatoid arthritis

Cannabinoids likely to be of limited value in rheumatoid arthritis

COVID-19 and immune-mediated inflammatory diseases

COVID-19 infection rates no higher among patients with immune-mediated inflammatory diseases

sleep disturbances in midlife women

Medication for sleep disturbance among midlife women of little benefit over longer-term

Beta blockers and effect on chronic pain

Beta-blockers associated with analgesic effect in osteoarthritis